Tag: John Longshore
Tumor Mutation Burden: Evolution of a Controversial Biomarker From the Pathologist’s...
By Lynette M. Sholl, MD, and John W. Longshore, PhD, FACMG
Posted: February 12, 2020
The profound impact of immunotherapy in patients with lung cancer has...
